Evidence map›Paper›PMID 42478256›Full record

ArticleTumori2026

Knowledge and resources gaps for adolescent and young adult (AYA) cancer patients: Results from survAYA, an Italian National Survey.

Alberto Puccini, Sara Farinatti, Alexia Francesca Bertuzzi, Giacomo Giulio Baldi, Alice Indini, Paola Quarello, Elena Pagani Bagliacca, Maurizio Mascarin, Marco Maruzzo, Matteo Lambertini and 11 more

Abstract read
In one paragraph

Article in Tumori, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Alberto PucciniDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.ORCID 0000-0002-2492-4043
Sara FarinattiDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
Alexia Francesca BertuzziMedical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
Giacomo Giulio BaldiDepartment of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy.
Alice IndiniMelanoma Medical Oncology Unit, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Paola QuarelloPediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Torino, University of Torino, Italy.ORCID 0000-0002-1940-7375
Elena Pagani BagliaccaPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Maurizio MascarinRadiotherapy Department, AYA Oncology and Paediatric Radiotherapy Unit, CRO Centro di Riferimento Oncologico IRCCS, Aviano, Italy.
Marco MaruzzoOncology Unit 3, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy.
Matteo LambertiniDepartment of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Lorena IncorvaiaDepartment of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), Section of Medical Oncology, University of Palermo, Palermo, Italy.
Giuseppe Maria MilanoDepartment of Paediatric Onco-Haematology and Cell and Gene Therapy, Bambino Gesù Children Hospital, Rome, Italy.ORCID 0000-0002-0250-6043
Giulia ZucchettiPediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Azienda Ospedaliera-Universitaria Città della Salute e della Scienza, Torino, University of Torino, Italy.ORCID 0000-0003-1437-3572
Assunta TorneselloPediatric Oncology Unit, Ospedale Vito Fazzi, Lecce, Italy.
Marco SpinelliPediatric Hematology-Oncology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Elisabetta RazzaboniHospital Psychology Unit, Azienda Ospedaliera Universitaria di Modena, Italy.
Teresa PerilloPediatric Hematology-Oncology Division, Department of Pediatrics, University of Bari, Bari, Italy.
Laura MarzialiC'è Tempo ODV, Ancona, Italy.
Andrea FerrariPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.ORCID 0000-0002-4724-0517
Fedro Alessandro PeccatoriGynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0001-8227-8740
Angela TossHospital Psychology Unit, Azienda Ospedaliera Universitaria di Modena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdolescents and young adults (AYA; 15-39 years) represent a distinct oncology population with specific biological and psychosocial needs. Despite growing awareness, AYA patients often face fragmented care between pediatric and adult settings, resulting in diagnostic delays, limited clinical trial access, and inadequate psychosocial support. In 2021, the AIOM-AIEOP AYA Working Group was established in Italy to promote awareness and address these challenges.

methodsAn anonymous, voluntary online survey was designed by the AIOM-AIEOP AYA Working Group and distributed during the AIOM National Congress (November 2024). Using iPads at a dedicated booth, oncologists and other healthcare professionals completed a questionnaire exploring knowledge, perceptions, and access to AYA-focused services. Data were analyzed using descriptive statistics.

resultsNinety-seven professionals participated (median age 34 years; 75% female; 56% medical oncologists). Although 86% reported access to genetic counseling and 84% to fertility preservation services, only 18% had AYA-dedicated spaces and 21% employed trained AYA-specific staff. Forty-four percent felt competent in assessing hereditary cancer syndromes, and fewer than 25% were aware of AYA-focused research or trials. Psychological support was commonly available, whereas educational coaching and peer support groups were rare (5% each). Lifestyle counseling was frequent, but structured survivorship care and long-term follow-up were limited.

conclusionsThis survey reveals substantial gaps in AYA oncology services in Italy, particularly regarding dedicated staff, infrastructure, and training. National coordination and implementation of standardized frameworks, such as through the AIOM-AIEOP network, are essential to ensure equitable, comprehensive care for AYA patients.

Indexed as

AYAknowledge gapspsychological supportsurveysurvivorship

Identifiers

PMID42478256
PMCPMC13687625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.